Jonathan Said - Concepedia

Author

Jonathan Said

University of California, Los Angeles ORCID

Also Known As

Dittmer, Dirk P., J SAID, J Said, J W Said, J. SAID, J. Said, J. W. Said, J.W. Said, JONATHAN SAID, JONATHAN W. SAID

606

Publications

31.9K

Citations

H-Index

177

Concepts

All Affiliations

University of California, Los Angeles Cedars-Sinai Medical Center National University of Singapore National University Cancer Institute, Singapore Los Angeles Medical Center

About

Jonathan Said is an author at University of California, Los Angeles specializing in medicine, pathology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	57	124	8.7K
2	Health Sciences	10	10	760
3	Natural Sciences	4	4	370
4	Engineering	2	2	79
5	Public Health	2	2	119

Jonathan Said

285

Publications

27.1K

Citations

H-Index

Page 1

	Year	Citations
Kaposi's Sarcoma–Associated Herpesvirus-Like DNA Sequences in AIDS-Related Body-Cavity–Based Lymphomas Ethel Cesarman, Yuan Chang, Patrick S. Moore, New England Journal of Medicine	1995	2.9K
Ligands for peroxisome proliferator-activated receptorγ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells <i>in vitro</i> and in BNX mice Elena Elstner, Carsten Müller‐Tidow, Kozo Koshizuka, Proceedings of the National Academy of Sciences	1998	795
Improved Prognostication of Renal Cell Carcinoma Using an Integrated Staging System Amnon Zisman, Allan J. Pantuck, Fredrick Dorey, Journal of Clinical Oncology	2001	727
Risk Group Assessment and Clinical Outcome Algorithm to Predict the Natural History of Patients With Surgically Resected Renal Cell Carcinoma Amnon Zisman, Allan J. Pantuck, Jeffery Wieder, Journal of Clinical Oncology	2002	663
Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression Young E. Whang, Xinyi Wu, Hiroyoshi Suzuki, Proceedings of the National Academy of Sciences	1998	636
Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. Tetsuya Kubota, Kozo Koshizuka, Elizabeth A. Williamson, PubMed Tumor BiologyUrologyMedicinePotent Antitumor EffectPharmacology	1998	588
Kaposi's Sarcoma-Associated Herpesvirus Infection of Bone Marrow Dendritic Cells from Multiple Myeloma Patients Matthew B. Rettig, Huffman K.J., Robert Vescio, Science	1997	480
ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes Edgardo R. Parrilla Castellar, Elaine S. Jaffe, Jonathan Said, Blood	2014	457
Programmed Death Ligand 1 Is Expressed by Non–Hodgkin Lymphomas and Inhibits the Activity of Tumor-Associated T Cells David Andorsky, Reiko Yamada, Jonathan Said, Clinical Cancer Research	2011	326
KSHV-Positive Solid Lymphomas Represent an Extra-Cavitary Variant of Primary Effusion Lymphoma Amy Chadburn, Elizabeth Hyjek, Susan Mathew, The American Journal of Surgical Pathology Primary ImmunodeficiencyLymphoid NeoplasiaPrimary Effusion LymphomaAnalyzed PelsHuman Retrovirus	2004	310

Page 1